Nifty

:

22713.10

Sensex

:

73319.55

33.70 (0.15%)
185.23 (0.25%)

Login

Nifty
Sensex

:
:

22713.10
73319.55

33.70 (0.15%)
185.23 (0.25%)

Oxygenta Pharmaceutical Ltd.

Pharmaceuticals & Drugs

Rating :

47/99

BSE: 524636 | NSE: Not Listed

Watchlist

NSE BSE

49.76

02-Apr-2026

Open
High
Low
Previous Close

48
49.8
45.36
47.99

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1268
62059
49.8
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

184.03
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

255.62
N/A
-4.50

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

24.28
16.00
52.22

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.88
-
6.50

PAT CAGR (%)

10 Years
5 Years
3 Years

5.82
-
-5.77

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-6.02
-6.02
-8.88

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-22.93
-23.53
-28.45

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 33.93 33.69 0.71% 14.25 14.76 -3.46% 15.13 12.62 19.89% 49.47 10.55 368.91%
Expenses 38.01 37.56 1.20% 18.88 16.18 16.69% 21.96 14.41 52.39% 51.15 12.17 320.30%
EBITDA -4.08 -3.87 - -4.63 -1.42 - -6.83 -1.78 - -1.68 -1.62 -
EBIDTM -12.01% -11.48% -32.51% -9.64% -45.13% -14.14% -3.40% -15.31%
Other Income 0.00 0.00 0 0.00 0.00 0 0.17 0.02 750.00% 0.05 0.01 400.00%
Interest 1.39 0.39 256.41% 0.95 0.69 37.68% 0.63 0.41 53.66% 2.13 0.60 255.00%
Depreciation 0.86 0.71 21.13% 0.86 0.66 30.30% 0.85 0.65 30.77% -0.23 0.64 -
PBT -6.33 -4.96 - -6.44 -2.77 - -8.15 -2.82 - -3.80 -2.59 -
Tax -1.48 -1.03 - -1.51 0.08 - -2.04 -1.45 - -1.65 -10.60 -
PAT -4.84 -3.93 - -4.93 -2.86 - -6.11 -1.36 - -2.15 8.02 -
PATM -14.27% -11.66% -34.61% -19.35% -40.34% -10.81% -4.35% 75.96%
EPS -1.31 -1.06 - -1.33 -0.77 - -1.65 -0.37 - -0.58 2.17 -

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 112.78 109.30 39.64 30.99 60.52 52.03 13.72 20.51 12.87 8.15 12.43 Net Sales Growth 57.47% 175.73% 27.91% -48.79% 16.32% 279.23% -33.11% 59.36% 57.91% -34.43% Cost Of Goods Sold 102.72 96.47 33.53 24.01 47.22 36.63 15.58 16.08 9.93 5.64 8.29 Gross Profit 10.06 12.83 6.11 6.98 13.30 15.40 -1.87 4.43 2.94 2.52 4.13 GP Margin 8.92% 11.74% 15.41% 22.52% 21.98% 29.60% -13.63% 21.60% 22.84% 30.92% 33.23% Total Expenditure 130.00 119.04 49.34 38.10 59.05 48.18 21.58 22.55 16.87 13.00 16.59 Power & Fuel Cost - 6.24 4.15 4.16 3.04 2.79 1.00 0.89 1.12 1.08 2.23 % Of Sales - 5.71% 10.47% 13.42% 5.02% 5.36% 7.29% 4.34% 8.70% 13.25% 17.94% Employee Cost - 6.90 5.99 5.74 0.92 4.08 2.50 2.71 2.90 2.86 3.07 % Of Sales - 6.31% 15.11% 18.52% 1.52% 7.84% 18.22% 13.21% 22.53% 35.09% 24.70% Manufacturing Exp. - 6.00 3.28 2.43 5.97 2.88 1.32 1.38 1.45 1.67 1.00 % Of Sales - 5.49% 8.27% 7.84% 9.86% 5.54% 9.62% 6.73% 11.27% 20.49% 8.05% General & Admin Exp. - 2.82 2.24 1.72 1.88 1.78 1.12 1.33 1.36 1.59 1.96 % Of Sales - 2.58% 5.65% 5.55% 3.11% 3.42% 8.16% 6.48% 10.57% 19.51% 15.77% Selling & Distn. Exp. - 0.40 0.11 0.04 0.00 0.01 0.05 0.10 0.04 0.11 0.02 % Of Sales - 0.37% 0.28% 0.13% 0% 0.02% 0.36% 0.49% 0.31% 1.35% 0.16% Miscellaneous Exp. - 0.22 0.02 0.01 0.01 0.01 0.01 0.06 0.06 0.05 0.02 % Of Sales - 0.20% 0.05% 0.03% 0.02% 0.02% 0.07% 0.29% 0.47% 0.61% 0.08% EBITDA -17.22 -9.74 -9.70 -7.11 1.47 3.85 -7.86 -2.04 -4.00 -4.85 -4.16 EBITDA Margin -15.27% -8.91% -24.47% -22.94% 2.43% 7.40% -57.29% -9.95% -31.08% -59.51% -33.47% Other Income 0.22 1.31 0.04 0.02 0.00 0.09 0.03 0.31 1.36 0.62 0.00 Interest 5.10 2.03 1.59 1.49 0.92 1.78 1.09 0.75 0.90 0.60 0.51 Depreciation 2.34 0.82 2.66 2.05 1.59 1.20 1.00 1.02 0.94 0.90 0.82 PBT -24.72 -11.28 -13.91 -10.64 -1.04 0.95 -9.93 -3.49 -4.48 -5.72 -5.50 Tax -6.68 -1.87 -10.39 0.20 0.12 0.21 -0.15 -0.24 0.05 0.09 0.00 Tax Rate 27.02% 16.19% 74.91% -1.76% -24.49% 6.69% 2.53% 6.88% -1.12% -1.57% 0.00% PAT -18.03 -9.68 -3.48 -11.57 -0.61 2.93 -5.79 -3.25 -4.53 -5.81 -5.50 PAT before Minority Interest -18.03 -9.68 -3.48 -11.57 -0.61 2.93 -5.79 -3.25 -4.53 -5.81 -5.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -15.99% -8.86% -8.78% -37.33% -1.01% 5.63% -42.20% -15.85% -35.20% -71.29% -44.25% PAT Growth 0.00% - - - - - - - - - EPS -4.87 -2.62 -0.94 -3.13 -0.16 0.79 -1.56 -0.88 -1.22 -1.57 -1.49

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds -25.02 -20.12 -46.20 -34.63 -38.02 -40.95 -35.16 -31.91 -27.38 -21.57 Share Capital 36.98 33.48 14.20 14.20 10.20 10.20 10.20 10.20 10.20 10.20 Total Reserves -62.01 -54.17 -60.40 -48.83 -48.22 -51.15 -45.36 -42.11 -37.58 -31.77 Non-Current Liabilities 11.80 40.89 67.57 57.74 54.39 43.72 39.59 30.73 30.68 20.59 Secured Loans 2.63 3.40 37.01 32.77 0.00 0.50 0.50 1.76 1.93 1.71 Unsecured Loans 18.89 45.60 25.24 18.27 45.04 24.94 20.37 16.26 16.56 14.94 Long Term Provisions 1.08 0.62 0.59 2.50 2.66 0.00 0.00 0.00 0.00 0.00 Current Liabilities 85.85 33.70 32.90 8.07 17.50 15.85 16.73 18.14 15.77 20.75 Trade Payables 29.79 22.89 23.78 6.46 13.79 8.10 8.95 10.76 9.26 15.14 Other Current Liabilities 15.88 3.27 3.58 0.41 0.77 6.27 6.31 6.15 5.85 5.14 Short Term Borrowings 39.94 7.46 4.97 1.09 2.85 0.50 0.49 0.24 0.00 0.00 Short Term Provisions 0.23 0.07 0.57 0.12 0.09 0.97 0.98 1.00 0.66 0.47 Total Liabilities 72.63 54.47 54.27 31.18 33.87 18.62 21.16 16.96 19.07 19.77 Net Block 39.63 29.36 27.91 19.98 16.31 11.42 11.90 12.29 12.45 12.80 Gross Block 61.49 50.53 46.43 36.44 31.18 25.10 24.58 23.99 23.21 22.67 Accumulated Depreciation 21.86 21.18 18.52 16.46 14.87 13.68 12.68 11.70 10.76 9.86 Non Current Assets 41.68 30.35 29.26 21.61 17.92 11.85 12.35 12.72 13.24 14.35 Capital Work in Progress 0.23 0.00 0.00 0.34 0.65 0.00 0.00 0.06 0.43 0.07 Non Current Investment 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Long Term Loans & Adv. 1.76 0.95 1.30 1.24 0.91 0.38 0.41 0.33 0.31 1.43 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 30.94 24.11 25.01 9.56 15.94 6.77 8.80 4.24 5.83 5.42 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 20.51 13.72 11.71 7.28 12.11 4.25 5.33 1.56 1.88 0.93 Sundry Debtors 5.10 7.36 10.16 1.58 1.61 0.42 0.51 0.48 0.86 1.48 Cash & Bank 0.12 0.10 0.11 0.16 0.45 0.12 0.02 0.01 0.02 0.01 Other Current Assets 5.21 0.04 0.02 0.01 1.77 1.97 2.94 2.19 3.06 2.99 Short Term Loans & Adv. 5.13 2.89 3.01 0.54 1.72 1.93 2.56 2.15 3.02 0.55 Net Current Assets -54.90 -9.59 -7.89 1.50 -1.55 -9.08 -7.92 -13.90 -9.94 -15.33 Total Assets 72.62 54.46 54.27 31.17 33.86 18.62 21.15 16.96 19.07 19.77

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 2.60 -13.05 -1.63 -1.68 -1.62 -2.59 -7.79 1.28 0.52 0.85 PBT -11.55 -13.87 -11.37 -0.49 3.14 -5.94 -3.49 -4.48 -5.72 -5.50 Adjustment 2.49 4.31 3.53 2.51 2.96 2.07 1.75 1.83 1.49 1.34 Changes in Working Capital 11.83 -3.49 6.20 -3.58 -7.51 1.13 -6.29 3.99 4.84 5.01 Cash after chg. in Working capital 2.76 -13.05 -1.63 -1.56 -1.41 -2.75 -8.03 1.33 0.60 0.85 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.16 0.00 0.00 -0.12 -0.21 0.15 0.24 -0.05 -0.09 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -11.25 -4.09 -9.64 -4.94 -6.72 -0.50 -0.56 -0.39 -0.90 -2.08 Net Fixed Assets -11.19 -4.10 -9.65 -4.95 -6.73 -0.52 -0.53 -0.41 -0.90 -2.09 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -0.06 0.01 0.01 0.01 0.01 0.02 -0.03 0.02 0.00 0.01 Cash from Financing Activity 8.67 17.13 11.22 6.33 8.67 3.19 8.36 -0.90 0.39 1.17 Net Cash Inflow / Outflow 0.02 -0.01 -0.05 -0.29 0.33 0.10 0.01 -0.01 0.01 -0.06 Opening Cash & Equivalents 0.10 0.11 0.16 0.45 0.12 0.02 0.01 0.02 0.01 0.08 Closing Cash & Equivalent 0.12 0.10 0.11 0.16 0.45 0.12 0.02 0.01 0.02 0.01

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) -6.77 -6.18 -32.53 -24.38 -37.27 -40.14 -34.47 -31.28 -26.84 -21.14 ROA -15.24% -6.40% -27.09% -1.88% 11.16% -29.10% -17.07% -25.13% -29.92% -29.05% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% ROCE -25.62% -41.69% -50.32% 3.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% Fixed Asset Turnover 1.95 0.82 0.75 1.79 1.85 0.55 0.84 0.55 0.36 0.57 Receivable days 20.80 80.66 69.12 9.61 7.13 12.49 8.84 19.04 52.52 31.21 Inventory Days 57.15 117.03 111.83 58.49 57.41 127.53 61.29 48.75 62.90 21.36 Payable days 99.66 254.01 229.85 78.25 109.07 199.77 144.78 221.93 344.21 299.32 Cash Conversion Cycle -21.70 -56.32 -48.90 -10.16 -44.52 -59.76 -74.64 -154.14 -228.80 -246.75 Total Debt/Equity -2.49 -2.77 -1.47 -1.51 -1.26 -0.66 -0.64 -0.60 -0.70 -0.80 Interest Cover -4.68 -7.70 -6.65 0.47 2.76 -4.43 -3.68 -3.96 -8.57 -9.75

Top Investors:

sravani reddy gantla

subba reddy bhimavarapu

sunil v. chawda

kumuda katasani

devarapally venkateswara reddy

aakanksha m chawda

manoj s. chawda

snigdha vankineni

satyanarayana reddy bandi

Annual Reports:

News Update:

Oxygenta Pharma - Quarterly Results
5th Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback